Our Latest Whitepaper

2026 moved faster than most of us expected, with trade and national security policy now shaping where drugs get made. Our outlook for 2027 looks at where demand is heading, where capacity is moving and how policy is reshaping supply chains, with a Talent Impact lens on every section.

‍

Inside, you’ll find

  • How our 2026 predictions held up, including where we got it wrong
  • Why oligo capacity is selling out before it’s built
  • What BIOSECURE and the new US tariffs mean for your supply chain and hiring plans
  • Five predictions for 2027 and seven imperatives for CDMO and CRO leaders
  • And much more...


Fill out the form below to get your copy

‍